68.72

3.54% 2.35

Pre-market: 69.49 0.77 +1.12%

Bio Techne Corp (TECH)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Bio Techne Corp stock is traded at $68.72, with a volume of 1.48M. It is up +3.54% in the last 24 hours and down -3.54% over the past month. Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

Previous Close:

$66.37

Open:

$66.29

24h Volume:

1.48M

Relative Volume:

1.66

Market Cap:

$10.92B

Revenue:

$1.17B

Net Income/Loss:

$150.71M

P/E Ratio:

45.21

EPS:

1.52

Net Cash Flow:

$245.03M

1W Performance:

-9.50%

1M Performance:

-3.54%

6M Performance:

-16.70%

1Y Performance:

+8.07%

1-Day Range:

$65.61

$68.92

1-Week Range:

$65.61

$75.84

52-Week Range:

$61.16

$85.57

Bio Techne Corp Stock (TECH) Company Profile

Name

Bio Techne Corp

Sector

Healthcare (1193)

Industry

Biotechnology (683)

Phone

(612) 379-8854

Address

614 MCKINLEY PL N E, MINNEAPOLIS, MN

Employee

3,100

Twitter

@biotechne

Next Earnings Date

2024-10-30

Latest SEC Filings

TECH's Discussions on Twitter

Compare TECH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TECH	68.72	10.92B	1.17B	150.71M	245.03M	1.52
VRTX	451.23	115.74B	10.63B	-479.80M	-1.35B	13.33
REGN	743.35	81.65B	13.85B	4.65B	3.32B	35.06
ARGX	591.82	34.86B	1.86B	-40.29M	-1.28B	-4.16
ALNY	248.79	32.09B	2.09B	-332.26M	16.06M	-4.14
BNTX	102.14	24.49B	3.30B	-501.07M	1.03B	11.54

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-22-24	Downgrade	Citigroup	Buy → Neutral
Feb-08-24	Initiated	Scotiabank	Sector Outperform
Feb-02-24	Downgrade	Stifel	Buy → Hold
Dec-07-23	Initiated	UBS	Buy
Aug-28-23	Initiated	William Blair	Outperform
Jan-10-23	Upgrade	Wells Fargo	Underweight → Equal Weight
Dec-14-22	Initiated	Deutsche Bank	Buy
Dec-12-22	Upgrade	Citigroup	Neutral → Buy
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform
Aug-25-22	Initiated	Credit Suisse	Outperform
Apr-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight
Sep-15-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Mar-08-21	Upgrade	Stephens	Equal-Weight → Overweight
Feb-23-21	Upgrade	Stifel	Hold → Buy
Jan-25-21	Reiterated	The Benchmark Company	Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-30-20	Initiated	Atlantic Equities	Overweight
Jul-15-20	Downgrade	Stephens	Overweight → Equal-Weight
May-27-20	Downgrade	Stifel	Buy → Hold
May-14-20	Initiated	The Benchmark Company	Buy
Jan-08-20	Resumed	Stephens	Overweight
Jan-08-20	Initiated	Wells Fargo	Equal Weight
Jan-07-20	Initiated	Citigroup	Neutral
Nov-15-19	Initiated	Stifel	Buy
Jul-02-19	Upgrade	Janney	Neutral → Buy
Jan-14-19	Upgrade	Stephens	Equal-Weight → Overweight
Oct-31-18	Downgrade	Craig Hallum	Buy → Hold
Oct-17-18	Initiated	Goldman	Neutral
Jun-15-18	Initiated	Argus	Buy
Jul-13-17	Initiated	Wells Fargo	Market Perform
Feb-09-17	Initiated	Citigroup	Buy
Jan-18-17	Initiated	Deutsche Bank	Buy
Nov-10-16	Resumed	Leerink Partners	Outperform
Jan-21-15	Reiterated	Robert W. Baird	Outperform
Sep-20-13	Upgrade	Robert W. Baird	Neutral → Outperform

View All

Bio Techne Corp Stock (TECH) Latest News

04:12 AM

Bio-Techne Co. (NASDAQ:TECH) Shares Acquired by Natixis Advisors LLC - MarketBeat

04:12 AM

Thrivent Financial for Lutherans Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

04:12 AM

Nov 20, 2024

Bio-Techne Gears Up for Q1 Earnings Release: What's in the Cards? - MSN

Nov 20, 2024

Bio-Techne To Present At Stephens NASH 2024 Conference; Webcast At 12:00 PM ET - Nasdaq

Nov 20, 2024

Bio-Techne partners with Leader Life Sciences in GCC - Investing.com

Nov 20, 2024

Segall Bryant & Hamill LLC Has $38.20 Million Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 20, 2024

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES - Yahoo Finance

Nov 20, 2024

Nov 18, 2024

BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH - Quantisnow

Nov 18, 2024

Nov 17, 2024

Broadcrest Asset Management LLC Has $15.99 Million Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 17, 2024

Nov 15, 2024

Royce & Associates LP Acquires 17,296 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 15, 2024

Nov 14, 2024

BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO - Quantisnow

Nov 14, 2024

Nov 13, 2024

Geneva Capital Management LLC Has $88.27 Million Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 13, 2024

Sumitomo Mitsui Trust Group Inc. Cuts Stock Holdings in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 13, 2024

Nov 12, 2024

Bio-Techne To Present At UBS Global Healthcare Conference; Webcast At 12:30 PM ET - Nasdaq

Nov 12, 2024

Bio-Techne (NASDAQ:TECH) Raised to Buy at StockNews.com - MarketBeat

Nov 12, 2024

Nov 11, 2024

UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS - Quantisnow

Nov 11, 2024

BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES - Marketscreener.com

Nov 11, 2024

BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS - Quantisnow

Nov 11, 2024

Nov 10, 2024

Bio-Techne Co. (NASDAQ:TECH) is Montanaro Asset Management Ltd's 3rd Largest Position - MarketBeat

Nov 10, 2024

Ownership Capital B.V. Sells 208,493 Shares of Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 10, 2024

When the Price of (TECH) Talks, People Listen - Stock Traders Daily

Nov 10, 2024

Nov 08, 2024

Bio-Techne Corporation: An Insight Into Its Market Position & Product Expansion in Diagnostics and Spatial Biology!Major Drivers - Smartkarma

Nov 08, 2024

Asset Management One Co. Ltd. Has $9.69 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH) - MarketBeat

Nov 08, 2024

Nov 07, 2024

ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy - Quantisnow

Nov 07, 2024

Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Van ECK Associates Corp - MarketBeat

Nov 07, 2024

Nov 06, 2024

There May Be Some Bright Spots In Bio-Techne's (NASDAQ:TECH) Earnings - Yahoo Finance

Nov 06, 2024

Ex-Dividend Reminder: Bio-Techne, Pfizer and Tompkins Financial - Nasdaq

Nov 06, 2024

BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING - WV News

Nov 06, 2024

Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) - Yahoo Finance

Nov 06, 2024

Nov 05, 2024

Bio-Techne (FRA:TE1) Change In Receivables : €-33 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 05, 2024

Bio-Techne Corporation (TECH) Announces Executive Compensation U - GuruFocus.com

Nov 05, 2024

Bio-Techne awards CFO restricted stock units for retention - Investing.com

Nov 05, 2024

TECH (Bio-Techne) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com

Nov 05, 2024

LUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH - Quantisnow

Nov 05, 2024

Bio-Techne Co. (NASDAQ:TECH) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 05, 2024

Nov 04, 2024

Bio-Techne Tops Q1 Earnings & Revenue Estimates, Stock Up in Premarket - MSN

Nov 04, 2024